| CSC | Cancer stem cell |
| FDA | Food and Drug Administration |
| PDAC | Pancreatic ductal adenocarcinoma |
| PaCSC | Pancreatic CSC |
| SRC | Proto-oncogene tyrosine-protein kinase SRC |
| SFKs | SRC-family kinases |
| FYN | Proto-oncogene tyrosine-protein kinase Fyn |
| YES | Yamaguchi sarcoma |
| BLK | B-lymphoid tyrosine kinase |
| FRL | FYN-related kinase |
| YRK | YES-related kinase |
| FGR | Gardner–Rasheed feline sarcoma |
| HCK | Hematopoietic cell kinase |
| LCK | Lymphocyte specific kinase |
| LYN | Tyrosine-protein kinase LYN |
| SRMS | SRC-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites |
| PDX | Patient-derived xenografts |
| TCGA | The Cancer Genome Atlas |
| NET | Neuroendocrine tumors |
| LNM | Lymph node metastasis |
| ADEX | Aberrantly differentiated endocrine exocrine |
| GSEA | Gene Set Enrichment Analysis |
| mTOR | Mammalian target of rapamycin, |
| TGF-ß | Tumor growth factor-beta |
| RNAseq | RNA sequencing |
| DAS | Dasatinib |
| PP2 | 4-Amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine |
| CXCR4 | C-X-C chemokine receptor type 4 |
| ABCG2 | ATP-binding cassette superfamily G member 2 |
| KLF4 | Kruppel-like factor 4 |
| SOX2 | SRY-box 2 |
| POU5F1 | POU Class 5 Homeobox 1 |
| RTqPCR | Real-time quantitative polymerase chain reaction |
| TN-BCSC | Triple-negative breast cancer stem cells |
| JAK2 | Janus kinase 2 |